Holdings
Corgi Genomics & Precision Medicine ETF
As of Jun 30, 2026, Corgi Genomics & Precision Medicine ETF reported 58 positions worth US$1.69M. Largest: Thermo Fisher Scientific Inc, Vertex Pharmaceuticals Incorporated and Alnylam Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | 264 | US$132K | first report | Jun 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 231 | US$115K | first report | Jun 30, 2026 |
| Alnylam Pharmaceuticals, Inc. | 220 | US$66,227 | first report | Jun 30, 2026 |
| Guardant Health, Inc. | 429 | US$64,363 | first report | Jun 30, 2026 |
| Moderna, Inc. | 913 | US$63,937 | first report | Jun 30, 2026 |
| Revolution Medicines, Inc. | 341 | US$63,862 | first report | Jun 30, 2026 |
| Illumina, Inc. | 363 | US$63,826 | first report | Jun 30, 2026 |
| Incyte Corporation | 462 | US$52,372 | first report | Jun 30, 2026 |
| Genmab A/s | 168 | US$45,930 | first report | Jun 30, 2026 |
| Bio-techne Corp | 605 | US$42,743 | first report | Jun 30, 2026 |